Prelude Capital Management, LLC Acadia Pharmaceuticals Inc Transaction History

Prelude Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $119,007 - $181,946	5,727 Added 52.7%	16,595 $519,000
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $226,489 - $363,751	10,868 New	10,868 $226,000
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $13,184 - $20,634	-362 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $14,212 - $19,088	362 New	362 $18,000
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $27,978 - $41,433	-884 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $32,009 - $45,437	884 New	884 $38,000
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $30,108 - $59,633	-1,355 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $13,618 - $16,422	-584 Reduced 30.12%	1,355 $36,000
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $31,353 - $53,089	1,939 New	1,939 $52,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.